#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-3	Sex	_
1-2	4-15	differences	_
1-3	16-18	in	_
1-4	19-22	the	_
1-5	23-34	interacting	_
1-6	35-40	roles	_
1-7	41-43	of	_
1-8	44-55	impulsivity	_
1-9	56-59	and	_
1-10	60-68	positive	_
1-11	69-76	alcohol	_
1-12	77-87	expectancy	_
1-13	88-90	in	_
1-14	91-98	problem	_
1-15	99-107	drinking	_
1-16	108-109	:	_
1-17	110-111	A	_
1-18	112-122	structural	_
1-19	123-128	brain	_
1-20	129-136	imaging	_
1-21	137-142	study	_
1-22	143-150	Alcohol	_
1-23	151-161	expectancy	_
1-24	162-165	and	_
1-25	166-177	impulsivity	_
1-26	178-181	are	_
1-27	182-192	implicated	_
1-28	193-195	in	_
1-29	196-203	alcohol	_
1-30	204-210	misuse	_
1-31	211-212	.	_

2-1	213-220	However	_
2-2	221-222	,	_
2-3	223-226	how	_
2-4	227-232	these	_
2-5	233-236	two	_
2-6	237-241	risk	_
2-7	242-249	factors	_
2-8	250-258	interact	_
2-9	259-261	to	_
2-10	262-271	determine	_
2-11	272-279	problem	_
2-12	280-288	drinking	_
2-13	289-292	and	_
2-14	293-300	whether	_
2-15	301-304	men	_
2-16	305-308	and	_
2-17	309-314	women	_
2-18	315-321	differ	_
2-19	322-324	in	_
2-20	325-330	these	_
2-21	331-335	risk	_
2-22	336-345	processes	_
2-23	346-352	remain	_
2-24	353-360	unclear	_
2-25	361-362	.	_

3-1	363-365	In	_
3-2	366-369	158	_
3-3	370-376	social	http://maven.renci.org/NeuroBridge/neurobridge#TheSocialFunctionQuestionnaire
3-4	377-385	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#TheSocialFunctionQuestionnaire
3-5	386-387	(	_
3-6	388-390	86	_
3-7	391-396	women	_
3-8	397-398	)	_
3-9	399-407	assessed	_
3-10	408-411	for	_
3-11	412-419	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-12	420-423	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-13	424-432	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-14	433-447	Identification	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-15	448-452	Test	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-16	453-454	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-17	455-460	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-18	461-462	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
3-19	463-464	,	_
3-20	465-473	positive	_
3-21	474-481	alcohol	_
3-22	482-492	expectancy	_
3-23	493-494	,	_
3-24	495-498	and	_
3-25	499-506	Barratt	_
3-26	507-518	impulsivity	_
3-27	519-520	,	_
3-28	521-523	we	_
3-29	524-532	examined	_
3-30	533-536	sex	_
3-31	537-548	differences	_
3-32	549-551	in	_
3-33	552-557	these	_
3-34	558-562	risk	_
3-35	563-572	processes	_
3-36	573-574	.	_

4-1	575-582	Further	_
4-2	583-584	,	_
4-3	585-589	with	_
4-4	590-600	structural	_
4-5	601-606	brain	_
4-6	607-614	imaging	_
4-7	615-616	,	_
4-8	617-619	we	_
4-9	620-628	examined	_
4-10	629-632	the	_
4-11	633-639	neural	_
4-12	640-645	bases	_
4-13	646-656	underlying	_
4-14	657-660	the	_
4-15	661-673	relationship	_
4-16	674-681	between	_
4-17	682-687	these	_
4-18	688-692	risk	_
4-19	693-700	factors	_
4-20	701-704	and	_
4-21	705-712	problem	_
4-22	713-721	drinking	_
4-23	722-723	.	_

5-1	724-727	The	_
5-2	728-735	results	_
5-3	736-738	of	_
5-4	739-746	general	_
5-5	747-753	linear	_
5-6	754-762	modeling	_
5-7	763-769	showed	_
5-8	770-774	that	_
5-9	775-782	alcohol	_
5-10	783-793	expectancy	_
5-11	794-798	best	_
5-12	799-808	predicted	_
5-13	809-816	problem	_
5-14	817-825	drinking	_
5-15	826-828	in	_
5-16	829-834	women	_
5-17	835-836	,	_
5-18	837-844	whereas	_
5-19	845-847	in	_
5-20	848-851	men	_
5-21	852-854	as	_
5-22	855-859	well	_
5-23	860-862	as	_
5-24	863-865	in	_
5-25	866-869	the	_
5-26	870-878	combined	_
5-27	879-884	group	_
5-28	885-892	alcohol	_
5-29	893-903	expectancy	_
5-30	904-907	and	_
5-31	908-919	impulsivity	_
5-32	920-930	interacted	_
5-33	931-933	to	_
5-34	934-938	best	_
5-35	939-946	predict	_
5-36	947-954	problem	_
5-37	955-963	drinking	_
5-38	964-965	.	_

6-1	966-973	Alcohol	_
6-2	974-984	expectancy	_
6-3	985-988	was	_
6-4	989-999	associated	_
6-5	1000-1004	with	_
6-6	1005-1014	decreased	_
6-7	1015-1019	gray	_
6-8	1020-1026	matter	_
6-9	1027-1033	volume	_
6-10	1034-1035	(	_
6-11	1036-1039	GMV	_
6-12	1040-1041	)	_
6-13	1042-1044	of	_
6-14	1045-1048	the	_
6-15	1049-1054	right	_
6-16	1055-1064	posterior	_
6-17	1065-1071	insula	_
6-18	1072-1074	in	_
6-19	1075-1080	women	_
6-20	1081-1084	and	_
6-21	1085-1088	the	_
6-22	1089-1100	interaction	_
6-23	1101-1103	of	_
6-24	1104-1111	alcohol	_
6-25	1112-1122	expectancy	_
6-26	1123-1126	and	_
6-27	1127-1138	impulsivity	_
6-28	1139-1142	was	_
6-29	1143-1153	associated	_
6-30	1154-1158	with	_
6-31	1159-1168	decreased	_
6-32	1169-1172	GMV	_
6-33	1173-1175	of	_
6-34	1176-1179	the	_
6-35	1180-1184	left	_
6-36	1185-1193	thalamus	_
6-37	1194-1196	in	_
6-38	1197-1202	women	_
6-39	1203-1206	and	_
6-40	1207-1210	men	_
6-41	1211-1219	combined	_
6-42	1220-1223	and	_
6-43	1224-1226	in	_
6-44	1227-1230	men	_
6-45	1231-1236	alone	_
6-46	1237-1238	,	_
6-47	1239-1245	albeit	_
6-48	1246-1250	less	_
6-49	1251-1264	significantly	_
6-50	1265-1266	.	_

7-1	1267-1272	These	_
7-2	1273-1277	risk	_
7-3	1278-1285	factors	_
7-4	1286-1294	mediated	_
7-5	1295-1298	the	_
7-6	1299-1310	correlation	_
7-7	1311-1318	between	_
7-8	1319-1322	GMV	_
7-9	1323-1326	and	_
7-10	1327-1334	problem	_
7-11	1335-1343	drinking	_
7-12	1344-1345	.	_

8-1	1346-1356	Conversely	_
8-2	1357-1358	,	_
8-3	1359-1365	models	_
8-4	1366-1371	where	_
8-5	1372-1375	GMV	_
8-6	1376-1384	resulted	_
8-7	1385-1389	from	_
8-8	1390-1397	problem	_
8-9	1398-1406	drinking	_
8-10	1407-1411	were	_
8-11	1412-1415	not	_
8-12	1416-1425	supported	_
8-13	1426-1427	.	_

9-1	1428-1433	These	_
9-2	1434-1437	new	_
9-3	1438-1446	findings	_
9-4	1447-1453	reveal	_
9-5	1454-1462	distinct	_
9-6	1463-1476	psychological	_
9-7	1477-1484	factors	_
9-8	1485-1489	that	_
9-9	1490-1497	dispose	_
9-10	1498-1501	men	_
9-11	1502-1505	and	_
9-12	1506-1511	women	_
9-13	1512-1514	to	_
9-14	1515-1522	problem	_
9-15	1523-1531	drinking	_
9-16	1532-1533	.	_

10-1	1534-1542	Although	_
10-2	1543-1552	mediation	_
10-3	1553-1561	analyses	_
10-4	1562-1565	did	_
10-5	1566-1569	not	_
10-6	1570-1579	determine	_
10-7	1580-1581	a	_
10-8	1582-1588	causal	_
10-9	1589-1593	link	_
10-10	1594-1595	,	_
10-11	1596-1599	GMV	_
10-12	1600-1609	reduction	_
10-13	1610-1612	in	_
10-14	1613-1616	the	_
10-15	1617-1623	insula	_
10-16	1624-1627	and	_
10-17	1628-1636	thalamus	_
10-18	1637-1640	may	_
10-19	1641-1650	represent	_
10-20	1651-1657	neural	_
10-21	1658-1667	phenotype	_
10-22	1668-1670	of	_
10-23	1671-1676	these	_
10-24	1677-1681	risk	_
10-25	1682-1691	processes	_
10-26	1692-1698	rather	_
10-27	1699-1703	than	_
10-28	1704-1707	the	_
10-29	1708-1719	consequence	_
10-30	1720-1722	of	_
10-31	1723-1730	alcohol	_
10-32	1731-1742	consumption	_
10-33	1743-1745	in	_
10-34	1746-1759	non-dependent	_
10-35	1760-1766	social	_
10-36	1767-1775	drinkers	_
10-37	1776-1777	.	_

11-1	1778-1781	The	_
11-2	1782-1789	results	_
11-3	1790-1793	add	_
11-4	1794-1796	to	_
11-5	1797-1800	the	_
11-6	1801-1808	alcohol	_
11-7	1809-1816	imaging	_
11-8	1817-1827	literature	_
11-9	1828-1833	which	_
11-10	1834-1837	has	_
11-11	1838-1845	largely	_
11-12	1846-1853	focused	_
11-13	1854-1856	on	_
11-14	1857-1866	dependent	_
11-15	1867-1878	individuals	_
11-16	1879-1882	and	_
11-17	1883-1887	help	_
11-18	1888-1897	elucidate	_
11-19	1898-1909	alterations	_
11-20	1910-1912	in	_
11-21	1913-1918	brain	_
11-22	1919-1929	structures	_
11-23	1930-1934	that	_
11-24	1935-1938	may	_
11-25	1939-1949	contribute	_
11-26	1950-1952	to	_
11-27	1953-1956	the	_
11-28	1957-1967	transition	_
11-29	1968-1972	from	_
11-30	1973-1979	social	_
11-31	1980-1982	to	_
11-32	1983-1991	habitual	_
11-33	1992-2000	drinking	_
11-34	2001-2002	.	_

12-1	2003-2013	Highlights	_
12-2	2014-2021	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
12-3	2022-2032	expectancy	_
12-4	2033-2034	(	_
12-5	2035-2037	AE	_
12-6	2038-2039	)	_
12-7	2040-2043	and	_
12-8	2044-2055	impulsivity	_
12-9	2056-2059	are	_
12-10	2060-2064	risk	_
12-11	2065-2072	factors	_
12-12	2073-2076	for	_
12-13	2077-2084	problem	_
12-14	2085-2093	drinking	_
12-15	2094-2095	.	_

13-1	2096-2098	AE	_
13-2	2099-2107	mediates	_
13-3	2108-2111	the	_
13-4	2112-2123	correlation	_
13-5	2124-2131	between	_
13-6	2132-2137	right	_
13-7	2138-2144	insula	_
13-8	2145-2148	GMV	_
13-9	2149-2152	and	_
13-10	2153-2160	problem	_
13-11	2161-2169	drinking	_
13-12	2170-2172	in	_
13-13	2173-2178	women	_
13-14	2179-2180	.	_

14-1	2181-2183	AE	_
14-2	2184-2187	and	_
14-3	2188-2199	impulsivity	_
14-4	2200-2209	interacts	_
14-5	2210-2212	to	_
14-6	2213-2220	mediate	_
14-7	2221-2225	left	_
14-8	2226-2234	thalamus	_
14-9	2235-2238	GMV	_
14-10	2239-2242	and	_
14-11	2243-2250	problem	_
14-12	2251-2259	drinking	_
14-13	2260-2262	in	_
14-14	2263-2266	all	_
14-15	2267-2268	.	_

15-1	2269-2275	Models	_
15-2	2276-2281	where	_
15-3	2282-2289	changes	_
15-4	2290-2292	in	_
15-5	2293-2296	GMV	_
15-6	2297-2299	as	_
15-7	2300-2301	a	_
15-8	2302-2308	result	_
15-9	2309-2311	of	_
15-10	2312-2319	problem	_
15-11	2320-2328	drinking	_
15-12	2329-2332	are	_
15-13	2333-2336	not	_
15-14	2337-2346	supported	_
15-15	2347-2348	.	_

16-1	2349-2358	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
16-2	2359-2362	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
16-3	2363-2370	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
16-4	2371-2379	Subjects	_
16-5	2380-2383	and	_
16-6	2384-2394	assessment	_
16-7	2395-2400	Study	_
16-8	2401-2413	participants	_
16-9	2414-2418	were	_
16-10	2419-2428	recruited	_
16-11	2429-2431	by	_
16-12	2432-2446	advertisements	_
16-13	2447-2449	in	_
16-14	2450-2455	local	_
16-15	2456-2466	newspapers	_
16-16	2467-2470	and	_
16-17	2471-2476	radio	_
16-18	2477-2485	stations	_
16-19	2486-2489	and	_
16-20	2490-2492	by	_
16-21	2493-2499	flyers	_
16-22	2500-2506	posted	_
16-23	2507-2509	in	_
16-24	2510-2513	the	_
16-25	2514-2521	greater	_
16-26	2522-2525	New	_
16-27	2526-2531	Haven	_
16-28	2532-2536	area	_
16-29	2537-2538	.	_

17-1	2539-2542	All	_
17-2	2543-2555	participants	_
17-3	2556-2560	were	_
17-4	2561-2569	screened	_
17-5	2570-2572	to	_
17-6	2573-2575	be	_
17-7	2576-2580	free	_
17-8	2581-2583	of	_
17-9	2584-2589	major	_
17-10	2590-2597	medical	_
17-11	2598-2605	illness	_
17-12	2606-2607	,	_
17-13	2608-2612	past	_
17-14	2613-2615	or	_
17-15	2616-2623	present	_
17-16	2624-2636	neurological	_
17-17	2637-2638	(	_
17-18	2639-2643	e.g.	_
17-19	2644-2645	,	_
17-20	2646-2654	epilepsy	_
17-21	2655-2656	,	_
17-22	2657-2665	learning	_
17-23	2666-2677	impairments	_
17-24	2678-2679	,	_
17-25	2680-2684	head	_
17-26	2685-2691	trauma	_
17-27	2692-2693	)	_
17-28	2694-2697	and	_
17-29	2698-2702	axis	_
17-30	2703-2704	I	_
17-31	2705-2716	psychiatric	_
17-32	2717-2726	illnesses	_
17-33	2727-2736	including	_
17-34	2737-2746	substance	_
17-35	2747-2750	use	_
17-36	2751-2760	disorders	_
17-37	2761-2762	(	_
17-38	2763-2769	SCID-I	_
17-39	2770-2773	for	_
17-40	2774-2780	DSM-IV	_
17-41	2781-2782	)	_
17-42	2783-2784	,	_
17-43	2785-2791	denied	_
17-44	2792-2799	current	_
17-45	2800-2803	use	_
17-46	2804-2806	of	_
17-47	2807-2814	illicit	_
17-48	2815-2825	substances	_
17-49	2826-2827	,	_
17-50	2828-2831	and	_
17-51	2832-2838	showed	_
17-52	2839-2847	negative	_
17-53	2848-2853	urine	_
17-54	2854-2864	toxicology	_
17-55	2865-2870	tests	_
17-56	2871-2874	for	_
17-57	2875-2885	stimulants	_
17-58	2886-2887	,	_
17-59	2888-2895	opioids	_
17-60	2896-2897	,	_
17-61	2898-2907	marijuana	_
17-62	2908-2909	,	_
17-63	2910-2913	and	_
17-64	2914-2929	benzodiazepines	_
17-65	2930-2932	at	_
17-66	2933-2936	the	_
17-67	2937-2941	time	_
17-68	2942-2944	of	_
17-69	2945-2952	initial	_
17-70	2953-2962	screening	_
17-71	2963-2966	and	_
17-72	2967-2971	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
17-73	2972-2973	.	_

18-1	2974-2984	Candidates	_
18-2	2985-2994	currently	_
18-3	2995-3000	using	_
18-4	3001-3004	any	_
18-5	3005-3017	psychotropic	_
18-6	3018-3029	medications	_
18-7	3030-3034	were	_
18-8	3035-3043	excluded	_
18-9	3044-3045	.	_

19-1	3046-3054	Pregnant	_
19-2	3055-3057	or	_
19-3	3058-3067	lactating	_
19-4	3068-3073	women	_
19-5	3074-3078	also	_
19-6	3079-3083	were	_
19-7	3084-3087	not	_
19-8	3088-3096	included	_
19-9	3097-3098	.	_

20-1	3099-3111	Participants	_
20-2	3112-3116	were	_
20-3	3117-3124	further	_
20-4	3125-3133	required	_
20-5	3134-3136	to	_
20-6	3137-3139	be	_
20-7	3140-3144	free	_
20-8	3145-3147	of	_
20-9	3148-3169	MRI-contraindications	_
20-10	3170-3175	based	_
20-11	3176-3178	on	_
20-12	3179-3182	the	_
20-13	3183-3187	Yale	_
20-14	3188-3196	Magnetic	_
20-15	3197-3206	Resonance	_
20-16	3207-3215	Research	_
20-17	3216-3222	Center	_
20-18	3223-3225	's	_
20-19	3226-3232	safety	_
20-20	3233-3243	guidelines	_
20-21	3244-3245	.	_

21-1	3246-3249	All	_
21-2	3250-3258	subjects	_
21-3	3259-3265	signed	_
21-4	3266-3267	a	_
21-5	3268-3275	written	_
21-6	3276-3284	informed	_
21-7	3285-3292	consent	_
21-8	3293-3294	,	_
21-9	3295-3297	in	_
21-10	3298-3308	accordance	_
21-11	3309-3311	to	_
21-12	3312-3313	a	_
21-13	3314-3322	protocol	_
21-14	3323-3331	approved	_
21-15	3332-3334	by	_
21-16	3335-3338	the	_
21-17	3339-3343	Yale	_
21-18	3344-3349	Human	_
21-19	3350-3363	Investigation	_
21-20	3364-3373	Committee	_
21-21	3374-3375	.	_

22-1	3376-3379	One	_
22-2	3380-3387	hundred	_
22-3	3388-3391	and	_
22-4	3392-3403	fifty-eight	_
22-5	3404-3410	social	http://maven.renci.org/NeuroBridge/neurobridge#TheSocialFunctionQuestionnaire
22-6	3411-3419	drinkers	http://maven.renci.org/NeuroBridge/neurobridge#TheSocialFunctionQuestionnaire
22-7	3420-3421	(	_
22-8	3422-3424	86	_
22-9	3425-3430	women	_
22-10	3431-3432	;	_
22-11	3433-3436	age	_
22-12	3437-3441	29.8	_
22-13	3442-3443	±	_
22-14	3444-3448	10.6	_
22-15	3449-3454	years	_
22-16	3455-3456	)	_
22-17	3457-3469	participated	_
22-18	3470-3472	in	_
22-19	3473-3476	the	_
22-20	3477-3482	study	_
22-21	3483-3484	.	_

23-1	3485-3488	All	_
23-2	3489-3501	participants	_
23-3	3502-3511	completed	_
23-4	3512-3526	questionnaires	_
23-5	3527-3536	regarding	_
23-6	3537-3542	their	_
23-7	3543-3550	alcohol	_
23-8	3551-3554	use	_
23-9	3555-3559	over	_
23-10	3560-3563	the	_
23-11	3564-3568	past	_
23-12	3569-3573	year	_
23-13	3574-3575	,	_
23-14	3576-3585	including	_
23-15	3586-3593	average	_
23-16	3594-3600	number	_
23-17	3601-3603	of	_
23-18	3604-3608	days	_
23-19	3609-3611	of	_
23-20	3612-3619	alcohol	_
23-21	3620-3623	use	_
23-22	3624-3627	and	_
23-23	3628-3631	the	_
23-24	3632-3639	average	_
23-25	3640-3646	number	_
23-26	3647-3649	of	_
23-27	3650-3656	drinks	_
23-28	3657-3665	consumed	_
23-29	3666-3669	per	_
23-30	3670-3678	occasion	_
23-31	3679-3680	,	_
23-32	3681-3687	framed	_
23-33	3688-3690	on	_
23-34	3691-3692	a	_
23-35	3693-3700	monthly	_
23-36	3701-3706	basis	_
23-37	3707-3708	,	_
23-38	3709-3712	and	_
23-39	3713-3717	were	_
23-40	3718-3727	evaluated	_
23-41	3728-3732	with	_
23-42	3733-3736	the	_
23-43	3737-3744	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
23-44	3745-3748	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
23-45	3749-3758	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
23-46	3759-3773	Identification	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
23-47	3774-3778	Test	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
23-48	3779-3780	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
23-49	3781-3786	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
23-50	3787-3788	,	_
23-51	3789-3790	.	_

24-1	3791-3796	AUDIT	_
24-2	3797-3803	scores	_
24-3	3804-3807	are	_
24-4	3808-3818	calculated	_
24-5	3819-3823	from	_
24-6	3824-3827	the	_
24-7	3828-3831	sum	_
24-8	3832-3834	of	_
24-9	3835-3838	ten	_
24-10	3839-3850	self-report	_
24-11	3851-3860	questions	_
24-12	3861-3870	regarding	_
24-13	3871-3876	level	_
24-14	3877-3879	of	_
24-15	3880-3887	alcohol	_
24-16	3888-3891	use	_
24-17	3892-3893	,	_
24-18	3894-3909	alcohol-related	_
24-19	3910-3918	problems	_
24-20	3919-3920	,	_
24-21	3921-3924	and	_
24-22	3925-3932	concern	_
24-23	3933-3942	expressed	_
24-24	3943-3945	by	_
24-25	3946-3952	others	_
24-26	3953-3956	for	_
24-27	3957-3960	one	_
24-28	3961-3963	's	_
24-29	3964-3972	drinking	_
24-30	3973-3981	behavior	_
24-31	3982-3983	.	_

25-1	3984-3988	Each	_
25-2	3989-3997	question	_
25-3	3998-4000	is	_
25-4	4001-4007	scored	_
25-5	4008-4012	from	_
25-6	4013-4014	0	_
25-7	4015-4017	to	_
25-8	4018-4019	4	_
25-9	4020-4021	,	_
25-10	4022-4026	with	_
25-11	4027-4033	higher	_
25-12	4034-4041	numbers	_
25-13	4042-4052	indicating	_
25-14	4053-4054	a	_
25-15	4055-4062	greater	_
25-16	4063-4068	level	_
25-17	4069-4071	of	_
25-18	4072-4076	risk	_
25-19	4077-4080	for	_
25-20	4081-4087	having	_
25-21	4088-4090	or	_
25-22	4091-4101	developing	_
25-23	4102-4104	an	_
25-24	4105-4112	alcohol	_
25-25	4113-4116	use	_
25-26	4117-4125	disorder	_
25-27	4126-4127	.	_

26-1	4128-4131	The	_
26-2	4132-4136	mean	_
26-3	4137-4138	(	_
26-4	4139-4140	±	_
26-5	4141-4143	SD	_
26-6	4144-4145	)	_
26-7	4146-4151	AUDIT	_
26-8	4152-4158	scores	_
26-9	4159-4163	were	_
26-10	4164-4167	4.1	_
26-11	4168-4169	(	_
26-12	4170-4171	±	_
26-13	4172-4175	3.4	_
26-14	4176-4177	)	_
26-15	4178-4181	for	_
26-16	4182-4187	women	_
26-17	4188-4189	,	_
26-18	4190-4193	6.5	_
26-19	4194-4195	(	_
26-20	4196-4197	±	_
26-21	4198-4201	4.7	_
26-22	4202-4203	)	_
26-23	4204-4207	for	_
26-24	4208-4211	men	_
26-25	4212-4213	,	_
26-26	4214-4217	and	_
26-27	4218-4221	5.2	_
26-28	4222-4223	(	_
26-29	4224-4225	±	_
26-30	4226-4229	4.2	_
26-31	4230-4231	)	_
26-32	4232-4235	for	_
26-33	4236-4241	women	_
26-34	4242-4245	and	_
26-35	4246-4249	men	_
26-36	4250-4258	combined	_
26-37	4259-4260	.	_

27-1	4261-4266	These	_
27-2	4267-4272	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
27-3	4273-4279	scores	_
27-4	4280-4288	appeared	_
27-5	4289-4291	to	_
27-6	4292-4294	be	_
27-7	4295-4302	typical	_
27-8	4303-4305	of	_
27-9	4306-4319	non-dependent	http://maven.renci.org/NeuroBridge/neurobridge#Abstinent
27-10	4320-4328	drinkers	_
27-11	4329-4332	and	_
27-12	4333-4337	were	_
27-13	4338-4351	significantly	_
27-14	4352-4357	lower	_
27-15	4358-4362	than	_
27-16	4363-4368	those	_
27-17	4369-4377	reported	_
27-18	4378-4381	for	_
27-19	4382-4389	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
27-20	4390-4399	dependent	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
27-21	4400-4411	individuals	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
27-22	4412-4413	.	_

28-1	4414-4415	A	_
28-2	4416-4423	summary	_
28-3	4424-4426	of	_
28-4	4427-4438	demographic	_
28-5	4439-4442	and	_
28-6	4443-4451	clinical	_
28-7	4452-4456	data	_
28-8	4457-4459	is	_
28-9	4460-4469	presented	_
28-10	4470-4472	in	_
28-11	4473-4478	Table	_
28-12	4479-4481	1A	_
28-13	4482-4483	.	_

29-1	4484-4496	Participants	_
29-2	4497-4501	were	_
29-3	4502-4510	assessed	_
29-4	4511-4515	with	_
29-5	4516-4519	the	_
29-6	4520-4527	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
29-7	4528-4538	Expectancy	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
29-8	4539-4552	Questionnaire	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
29-9	4553-4554	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
29-10	4555-4560	AEQ-3	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
29-11	4561-4562	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
29-12	4563-4566	and	_
29-13	4567-4570	the	_
29-14	4571-4578	Barratt	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale
29-15	4579-4590	Impulsivity	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale
29-16	4591-4596	Scale	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale
29-17	4597-4598	(	http://maven.renci.org/NeuroBridge/neurobridge#ImpulsivityScale
29-18	4599-4605	BIS-11	_
29-19	4606-4607	,	_
29-20	4608-4609	)	_
29-21	4610-4611	.	_

30-1	4612-4615	The	_
30-2	4616-4619	AEQ	_
30-3	4620-4629	underwent	_
30-4	4630-4637	several	_
30-5	4638-4647	revisions	_
30-6	4648-4653	since	_
30-7	4654-4657	its	_
30-8	4658-4670	introduction	_
30-9	4671-4673	by	_
30-10	4674-4675	,	_
30-11	4676-4679	and	_
30-12	4680-4685	AEQ-3	_
30-13	4686-4695	consisted	_
30-14	4696-4698	of	_
30-15	4699-4701	40	_
30-16	4702-4707	items	_
30-17	4708-4710	to	_
30-18	4711-4718	address	_
30-19	4719-4723	both	_
30-20	4724-4732	positive	_
30-21	4733-4734	(	_
30-22	4735-4736	6	_
30-23	4737-4746	subscales	_
30-24	4747-4748	)	_
30-25	4749-4752	and	_
30-26	4753-4761	negative	_
30-27	4762-4763	(	_
30-28	4764-4765	2	_
30-29	4766-4775	subscales	_
30-30	4776-4777	)	_
30-31	4778-4785	alcohol	_
30-32	4786-4796	expectancy	_
30-33	4797-4798	.	_

31-1	4799-4803	Each	_
31-2	4804-4812	subscale	_
31-3	4813-4821	contains	_
31-4	4822-4823	4	_
31-5	4824-4826	to	_
31-6	4827-4828	6	_
31-7	4829-4839	statements	_
31-8	4840-4844	that	_
31-9	4845-4848	can	_
31-10	4849-4851	be	_
31-11	4852-4860	endorsed	_
31-12	4861-4863	on	_
31-13	4864-4865	a	_
31-14	4866-4875	six-point	_
31-15	4876-4881	scale	_
31-16	4882-4883	,	_
31-17	4884-4888	from	_
31-18	4889-4890	“	_
31-19	4891-4899	disagree	_
31-20	4900-4908	strongly	_
31-21	4909-4910	(	_
31-22	4911-4912	1	_
31-23	4913-4914	)	_
31-24	4915-4916	”	_
31-25	4917-4919	to	_
31-26	4920-4921	“	_
31-27	4922-4927	agree	_
31-28	4928-4936	strongly	_
31-29	4937-4938	(	_
31-30	4939-4940	6	_
31-31	4941-4942	)	_
31-32	4943-4944	”	_
31-33	4945-4946	.	_

32-1	4947-4950	The	_
32-2	4951-4957	global	_
32-3	4958-4966	positive	_
32-4	4967-4975	subscale	_
32-5	4976-4984	contains	_
32-6	4985-4989	five	_
32-7	4990-4995	items	_
32-8	4996-4999	and	_
32-9	5000-5004	thus	_
32-10	5005-5011	ranges	_
32-11	5012-5016	from	_
32-12	5017-5018	5	_
32-13	5019-5021	to	_
32-14	5022-5024	30	_
32-15	5025-5027	in	_
32-16	5028-5033	total	_
32-17	5034-5039	score	_
32-18	5040-5041	,	_
32-19	5042-5046	with	_
32-20	5047-5048	a	_
32-21	5049-5056	greater	_
32-22	5057-5062	score	_
32-23	5063-5073	indicating	_
32-24	5074-5080	higher	_
32-25	5081-5087	global	_
32-26	5088-5096	positive	_
32-27	5097-5104	alcohol	_
32-28	5105-5115	expectancy	_
32-29	5116-5117	.	_

33-1	5118-5126	Although	_
33-2	5127-5130	the	_
33-3	5131-5141	expectancy	_
33-4	5142-5155	subcomponents	_
33-5	5156-5159	are	_
33-6	5160-5173	statistically	_
33-7	5174-5185	discernible	_
33-8	5186-5187	,	_
33-9	5188-5191	the	_
33-10	5192-5196	high	_
33-11	5197-5205	subscale	_
33-12	5206-5224	inter-correlations	_
33-13	5225-5226	(	_
33-14	5227-5234	ranging	_
33-15	5235-5239	from	_
33-16	5240-5241	r	_
33-17	5242-5243	=	_
33-18	5244-5248	0.42	_
33-19	5249-5251	to	_
33-20	5252-5256	0.92	_
33-21	5257-5258	,	_
33-22	5259-5263	mean	_
33-23	5264-5265	=	_
33-24	5266-5270	0.78	_
33-25	5271-5272	)	_
33-26	5273-5280	suggest	_
33-27	5281-5285	that	_
33-28	5286-5289	the	_
33-29	5290-5296	degree	_
33-30	5297-5299	of	_
33-31	5300-5315	distinctiveness	_
33-32	5316-5321	among	_
33-33	5322-5325	the	_
33-34	5326-5335	subscales	_
33-35	5336-5338	is	_
33-36	5339-5341	at	_
33-37	5342-5346	best	_
33-38	5347-5353	modest	_
33-39	5354-5355	.	_

34-1	5356-5360	Thus	_
34-2	5361-5362	,	_
34-3	5363-5365	in	_
34-4	5366-5369	the	_
34-5	5370-5377	current	_
34-6	5378-5383	study	_
34-7	5384-5385	,	_
34-8	5386-5388	we	_
34-9	5389-5396	focused	_
34-10	5397-5399	on	_
34-11	5400-5403	the	_
34-12	5404-5405	“	_
34-13	5406-5412	global	_
34-14	5413-5421	positive	_
34-15	5422-5423	”	_
34-16	5424-5426	as	_
34-17	5427-5428	a	_
34-18	5429-5437	variable	_
34-19	5438-5440	to	_
34-20	5441-5449	identify	_
34-21	5450-5453	the	_
34-22	5454-5463	influence	_
34-23	5464-5466	of	_
34-24	5467-5474	alcohol	_
34-25	5475-5485	expectancy	_
34-26	5486-5488	on	_
34-27	5489-5502	inter-subject	_
34-28	5503-5513	variations	_
34-29	5514-5516	in	_
34-30	5517-5522	AUDIT	_
34-31	5523-5528	score	_
34-32	5529-5530	.	_

35-1	5531-5535	Used	_
35-2	5536-5538	to	_
35-3	5539-5547	evaluate	_
35-4	5548-5550	an	_
35-5	5551-5560	impulsive	_
35-6	5561-5572	personality	_
35-7	5573-5578	trait	_
35-8	5579-5580	,	_
35-9	5581-5584	the	_
35-10	5585-5591	BIS-11	_
35-11	5592-5594	is	_
35-12	5595-5596	a	_
35-13	5597-5604	30-item	_
35-14	5605-5616	self-report	_
35-15	5617-5630	questionnaire	_
35-16	5631-5639	designed	_
35-17	5640-5642	to	_
35-18	5643-5650	measure	_
35-19	5651-5662	impulsivity	_
35-20	5663-5664	.	_

36-1	5665-5668	All	_
36-2	5669-5674	items	_
36-3	5675-5678	are	_
36-4	5679-5685	scored	_
36-5	5686-5688	on	_
36-6	5689-5690	a	_
36-7	5691-5698	4-point	_
36-8	5699-5704	scale	_
36-9	5705-5706	(	_
36-10	5707-5708	1	_
36-11	5709-5710	=	_
36-12	5711-5723	rarely/never	_
36-13	5724-5725	;	_
36-14	5726-5727	2	_
36-15	5728-5729	=	_
36-16	5730-5742	occasionally	_
36-17	5743-5744	;	_
36-18	5745-5746	3	_
36-19	5747-5748	=	_
36-20	5749-5754	often	_
36-21	5755-5756	;	_
36-22	5757-5758	4	_
36-23	5759-5760	=	_
36-24	5761-5767	almost	_
36-25	5768-5781	always/always	_
36-26	5782-5783	)	_
36-27	5784-5785	.	_

37-1	5786-5789	The	_
37-2	5790-5795	total	_
37-3	5796-5801	score	_
37-4	5802-5806	thus	_
37-5	5807-5813	ranges	_
37-6	5814-5818	from	_
37-7	5819-5821	30	_
37-8	5822-5824	to	_
37-9	5825-5828	120	_
37-10	5829-5830	,	_
37-11	5831-5835	with	_
37-12	5836-5837	a	_
37-13	5838-5844	higher	_
37-14	5845-5850	score	_
37-15	5851-5861	indicating	_
37-16	5862-5871	increased	_
37-17	5872-5883	impulsivity	_
37-18	5884-5885	.	_

38-1	5886-5892	Eleven	_
38-2	5893-5895	of	_
38-3	5896-5899	the	_
38-4	5900-5902	30	_
38-5	5903-5908	items	_
38-6	5909-5912	are	_
38-7	5913-5920	reverse	_
38-8	5921-5927	scored	_
38-9	5928-5930	to	_
38-10	5931-5936	avoid	_
38-11	5937-5945	response	_
38-12	5946-5950	bias	_
38-13	5951-5952	.	_

39-1	5953-5956	The	_
39-2	5957-5963	BIS-11	_
39-3	5964-5967	has	_
39-4	5968-5972	been	_
39-5	5973-5983	translated	_
39-6	5984-5988	into	_
39-7	5989-5993	many	_
39-8	5994-6003	different	_
39-9	6004-6013	languages	_
39-10	6014-6018	with	_
39-11	6019-6023	good	_
39-12	6024-6032	internal	_
39-13	6033-6044	consistency	_
39-14	6045-6048	and	_
39-15	6049-6060	test–retest	_
39-16	6061-6072	reliability	_
39-17	6073-6074	.	_

40-1	6075-6083	Clinical	_
40-2	6084-6088	data	_
40-3	6089-6097	analysis	_
40-4	6098-6100	We	_
40-5	6101-6110	performed	_
40-6	6111-6117	linear	_
40-7	6118-6129	regressions	_
40-8	6130-6132	of	_
40-9	6133-6138	AUDIT	_
40-10	6139-6144	score	_
40-11	6145-6152	against	_
40-12	6153-6160	alcohol	_
40-13	6161-6178	expectancy-global	_
40-14	6179-6187	positive	_
40-15	6188-6193	score	_
40-16	6194-6195	(	_
40-17	6196-6198	GP	_
40-18	6199-6200	)	_
40-19	6201-6202	,	_
40-20	6203-6210	Barratt	_
40-21	6211-6222	Impulsivity	_
40-22	6223-6228	Scale	_
40-23	6229-6234	total	_
40-24	6235-6240	score	_
40-25	6241-6242	(	_
40-26	6243-6245	BI	_
40-27	6246-6247	)	_
40-28	6248-6249	,	_
40-29	6250-6253	and	_
40-30	6254-6257	the	_
40-31	6258-6269	interaction	_
40-32	6270-6272	of	_
40-33	6273-6275	BI	_
40-34	6276-6279	and	_
40-35	6280-6282	GP	_
40-36	6283-6285	or	_
40-37	6286-6288	BI	_
40-38	6289-6290	×	_
40-39	6291-6293	GP	_
40-40	6294-6295	,	_
40-41	6296-6300	each	_
40-42	6301-6304	for	_
40-43	6305-6308	men	_
40-44	6309-6310	,	_
40-45	6311-6316	women	_
40-46	6317-6320	and	_
40-47	6321-6324	the	_
40-48	6325-6333	combined	_
40-49	6334-6340	sample	_
40-50	6341-6342	,	_
40-51	6343-6345	to	_
40-52	6346-6352	assess	_
40-53	6353-6356	the	_
40-54	6357-6368	association	_
40-55	6369-6371	of	_
40-56	6372-6379	problem	_
40-57	6380-6388	drinking	_
40-58	6389-6393	with	_
40-59	6394-6399	these	_
40-60	6400-6404	risk	_
40-61	6405-6414	variables	_
40-62	6415-6416	.	_

41-1	6417-6424	Further	_
41-2	6425-6426	,	_
41-3	6427-6429	in	_
41-4	6430-6437	general	_
41-5	6438-6444	linear	_
41-6	6445-6451	models	_
41-7	6452-6453	(	_
41-8	6454-6457	GLM	_
41-9	6458-6459	)	_
41-10	6460-6461	,	_
41-11	6462-6464	we	_
41-12	6465-6475	considered	_
41-13	6476-6481	AUDIT	_
41-14	6482-6487	score	_
41-15	6488-6490	as	_
41-16	6491-6494	the	_
41-17	6495-6504	dependent	_
41-18	6505-6513	variable	_
41-19	6514-6517	and	_
41-20	6518-6520	GP	_
41-21	6521-6522	,	_
41-22	6523-6525	BI	_
41-23	6526-6527	,	_
41-24	6528-6534	and/or	_
41-25	6535-6538	the	_
41-26	6539-6550	interaction	_
41-27	6551-6555	term	_
41-28	6556-6558	BI	_
41-29	6559-6560	×	_
41-30	6561-6563	GP	_
41-31	6564-6565	,	_
41-32	6566-6568	as	_
41-33	6569-6571	an	_
41-34	6572-6583	independent	_
41-35	6584-6585	(	_
41-36	6586-6590	risk	_
41-37	6591-6592	)	_
41-38	6593-6601	variable	_
41-39	6602-6603	,	_
41-40	6604-6607	all	_
41-41	6608-6612	with	_
41-42	6613-6616	age	_
41-43	6617-6619	as	_
41-44	6620-6621	a	_
41-45	6622-6631	covariate	_
41-46	6632-6633	:	_
41-47	6634-6639	Model	_
41-48	6640-6641	1	_
41-49	6642-6643	:	_
41-50	6644-6649	AUDIT	_
41-51	6650-6651	=	_
41-52	6652-6654	β0	_
41-53	6655-6656	+	_
41-54	6657-6659	β1	_
41-55	6660-6661	×	_
41-56	6662-6664	GP	_
41-57	6665-6666	+	_
41-58	6667-6669	β2	_
41-59	6670-6671	×	_
41-60	6672-6674	BI	_
41-61	6675-6676	+	_
41-62	6677-6678	ε	_
41-63	6679-6680	.	_

42-1	6681-6686	Model	_
42-2	6687-6688	2	_
42-3	6689-6690	:	_
42-4	6691-6696	AUDIT	_
42-5	6697-6698	=	_
42-6	6699-6701	β0	_
42-7	6702-6703	+	_
42-8	6704-6706	β1	_
42-9	6707-6708	×	_
42-10	6709-6711	GP	_
42-11	6712-6713	+	_
42-12	6714-6716	β2	_
42-13	6717-6718	×	_
42-14	6719-6721	BI	_
42-15	6722-6723	+	_
42-16	6724-6726	β3	_
42-17	6727-6728	×	_
42-18	6729-6731	BI	_
42-19	6732-6733	×	_
42-20	6734-6736	GP	_
42-21	6737-6738	+	_
42-22	6739-6740	ε	_
42-23	6741-6746	Model	_
42-24	6747-6748	3	_
42-25	6749-6750	:	_
42-26	6751-6756	AUDIT	_
42-27	6757-6758	=	_
42-28	6759-6761	β0	_
42-29	6762-6763	+	_
42-30	6764-6766	β1	_
42-31	6767-6768	×	_
42-32	6769-6771	GP	_
42-33	6772-6773	+	_
42-34	6774-6775	ε	_
42-35	6776-6781	Model	_
42-36	6782-6783	4	_
42-37	6784-6785	:	_
42-38	6786-6791	AUDIT	_
42-39	6792-6793	=	_
42-40	6794-6796	β0	_
42-41	6797-6798	+	_
42-42	6799-6801	β1	_
42-43	6802-6803	×	_
42-44	6804-6806	BI	_
42-45	6807-6808	+	_
42-46	6809-6810	ε	_
42-47	6811-6816	Model	_
42-48	6817-6818	5	_
42-49	6819-6820	:	_
42-50	6821-6826	AUDIT	_
42-51	6827-6828	=	_
42-52	6829-6831	β0	_
42-53	6832-6833	+	_
42-54	6834-6836	β1	_
42-55	6837-6838	×	_
42-56	6839-6841	BI	_
42-57	6842-6843	×	_
42-58	6844-6846	GP	_
42-59	6847-6848	+	_
42-60	6849-6850	ε	_
42-61	6851-6856	Model	_
42-62	6857-6858	6	_
42-63	6859-6860	:	_
42-64	6861-6866	AUDIT	_
42-65	6867-6868	=	_
42-66	6869-6871	β0	_
42-67	6872-6873	+	_
42-68	6874-6876	β1	_
42-69	6877-6878	×	_
42-70	6879-6881	GP	_
42-71	6882-6883	+	_
42-72	6884-6886	β2	_
42-73	6887-6888	×	_
42-74	6889-6891	BI	_
42-75	6892-6893	×	_
42-76	6894-6896	GP	_
42-77	6897-6898	+	_
42-78	6899-6900	ε	_
42-79	6901-6906	Model	_
42-80	6907-6908	7	_
42-81	6909-6910	:	_
42-82	6911-6916	AUDIT	_
42-83	6917-6918	=	_
42-84	6919-6921	β0	_
42-85	6922-6923	+	_
42-86	6924-6926	β1	_
42-87	6927-6928	×	_
42-88	6929-6931	BI	_
42-89	6932-6933	+	_
42-90	6934-6936	β2	_
42-91	6937-6938	×	_
42-92	6939-6941	BI	_
42-93	6942-6943	×	_
42-94	6944-6946	GP	_
42-95	6947-6948	+	_
42-96	6949-6950	ε	_
42-97	6951-6956	where	_
42-98	6957-6958	β	_
42-99	6959-6961	's	_
42-100	6962-6973	represented	_
42-101	6974-6977	the	_
42-102	6978-6990	coefficients	_
42-103	6991-6994	and	_
42-104	6995-6996	ε	_
42-105	6997-6999	's	_
42-106	7000-7003	the	_
42-107	7004-7009	error	_
42-108	7010-7015	terms	_
42-109	7016-7017	.	_

43-1	7018-7021	The	_
43-2	7022-7028	models	_
43-3	7029-7033	were	_
43-4	7034-7040	ranked	_
43-5	7041-7046	using	_
43-6	7047-7050	the	_
43-7	7051-7059	Bayesian	_
43-8	7060-7071	information	_
43-9	7072-7081	criterion	_
43-10	7082-7083	(	_
43-11	7084-7087	BIC	_
43-12	7088-7089	)	_
43-13	7090-7092	as	_
43-14	7093-7097	well	_
43-15	7098-7100	as	_
43-16	7101-7104	the	_
43-17	7105-7111	Akaike	_
43-18	7112-7123	information	_
43-19	7124-7133	criterion	_
43-20	7134-7135	(	_
43-21	7136-7139	AIC	_
43-22	7140-7141	)	_
43-23	7142-7143	.	_

44-1	7144-7147	The	_
44-2	7148-7151	GLM	_
44-3	7152-7154	's	_
44-4	7155-7159	were	_
44-5	7160-7169	performed	_
44-6	7170-7172	in	_
44-7	7173-7179	Matlab	_
44-8	7180-7186	R2015b	_
44-9	7187-7192	using	_
44-10	7193-7204	Econometric	_
44-11	7205-7208	and	_
44-12	7209-7219	Statistics	_
44-13	7220-7229	toolboxes	_
44-14	7230-7233	for	_
44-15	7234-7239	women	_
44-16	7240-7243	and	_
44-17	7244-7247	men	_
44-18	7248-7256	combined	_
44-19	7257-7258	,	_
44-20	7259-7261	as	_
44-21	7262-7266	well	_
44-22	7267-7269	as	_
44-23	7270-7273	for	_
44-24	7274-7279	women	_
44-25	7280-7283	and	_
44-26	7284-7287	men	_
44-27	7288-7298	separately	_
44-28	7299-7300	.	_

45-1	7301-7308	Imaging	_
45-2	7309-7317	protocol	_
45-3	7318-7321	All	_
45-4	7322-7334	participants	_
45-5	7335-7339	were	_
45-6	7340-7347	scanned	_
45-7	7348-7350	on	_
45-8	7351-7352	a	_
45-9	7353-7360	Siemens	_
45-10	7361-7368	3-Tesla	http://maven.renci.org/NeuroBridge/neurobridge#DateTimeUnit
45-11	7369-7376	scanner	_
45-12	7377-7378	(	_
45-13	7379-7383	Trio	_
45-14	7384-7385	;	_
45-15	7386-7393	Siemens	_
45-16	7394-7396	AG	_
45-17	7397-7398	,	_
45-18	7399-7407	Erlangen	_
45-19	7408-7409	,	_
45-20	7410-7417	Germany	_
45-21	7418-7419	)	_
45-22	7420-7421	.	_

46-1	7422-7426	Data	_
46-2	7427-7430	for	_
46-3	7431-7435	each	_
46-4	7436-7447	participant	_
46-5	7448-7457	consisted	_
46-6	7458-7460	of	_
46-7	7461-7462	a	_
46-8	7463-7469	single	_
46-9	7470-7485	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
46-10	7486-7497	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
46-11	7498-7511	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
46-12	7512-7516	scan	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
46-13	7517-7518	:	_
46-14	7519-7522	176	_
46-15	7523-7529	slices	_
46-16	7530-7531	;	_
46-17	7532-7533	1	_
46-18	7534-7537	mm3	_
46-19	7538-7547	isotropic	_
46-20	7548-7554	voxels	_
46-21	7555-7556	;	_
46-22	7557-7562	field	_
46-23	7563-7565	of	_
46-24	7566-7570	view	_
46-25	7571-7572	=	_
46-26	7573-7576	256	_
46-27	7577-7578	×	_
46-28	7579-7582	256	_
46-29	7583-7585	mm	_
46-30	7586-7587	;	_
46-31	7588-7592	data	_
46-32	7593-7604	acquisition	_
46-33	7605-7611	matrix	_
46-34	7612-7613	=	_
46-35	7614-7617	256	_
46-36	7618-7619	×	_
46-37	7620-7623	256	_
46-38	7624-7625	;	_
46-39	7626-7628	TR	_
46-40	7629-7630	=	_
46-41	7631-7635	2530	_
46-42	7636-7638	ms	_
46-43	7639-7640	;	_
46-44	7641-7643	TE	_
46-45	7644-7645	=	_
46-46	7646-7650	3.66	_
46-47	7651-7653	ms	_
46-48	7654-7655	,	_
46-49	7656-7665	bandwidth	_
46-50	7666-7667	=	_
46-51	7668-7671	181	_
46-52	7672-7680	Hz/pixel	_
46-53	7681-7682	;	_
46-54	7683-7687	flip	_
46-55	7688-7693	angle	_
46-56	7694-7695	=	_
46-57	7696-7698	7°	_
46-58	7699-7700	.	_

47-1	7701-7712	Voxel-based	_
47-2	7713-7724	morphometry	_
47-3	7725-7726	(	_
47-4	7727-7730	VBM	_
47-5	7731-7732	)	_
47-6	7733-7736	The	_
47-7	7737-7740	aim	_
47-8	7741-7743	of	_
47-9	7744-7747	VBM	_
47-10	7748-7750	is	_
47-11	7751-7753	to	_
47-12	7754-7762	identify	_
47-13	7763-7774	differences	_
47-14	7775-7777	in	_
47-15	7778-7781	the	_
47-16	7782-7787	local	_
47-17	7788-7799	composition	_
47-18	7800-7802	of	_
47-19	7803-7808	brain	_
47-20	7809-7815	tissue	_
47-21	7816-7819	and	_
47-22	7820-7823	its	_
47-23	7824-7835	association	_
47-24	7836-7840	with	_
47-25	7841-7851	behavioral	_
47-26	7852-7855	and	_
47-27	7856-7865	cognitive	_
47-28	7866-7874	measures	_
47-29	7875-7876	,	_
47-30	7877-7882	while	_
47-31	7883-7894	discounting	_
47-32	7895-7900	large	_
47-33	7901-7906	scale	_
47-34	7907-7918	differences	_
47-35	7919-7921	in	_
47-36	7922-7927	gross	_
47-37	7928-7935	anatomy	_
47-38	7936-7939	and	_
47-39	7940-7948	position	_
47-40	7949-7950	.	_

48-1	7951-7955	This	_
48-2	7956-7959	can	_
48-3	7960-7962	be	_
48-4	7963-7971	achieved	_
48-5	7972-7974	by	_
48-6	7975-7984	spatially	_
48-7	7985-7996	normalizing	_
48-8	7997-8008	individuals	_
48-9	8009-8010	'	_
48-10	8011-8021	structural	_
48-11	8022-8028	images	_
48-12	8029-8031	to	_
48-13	8032-8035	the	_
48-14	8036-8040	same	_
48-15	8041-8053	stereotactic	_
48-16	8054-8059	space	_
48-17	8060-8061	,	_
48-18	8062-8072	segmenting	_
48-19	8073-8076	the	_
48-20	8077-8087	normalized	_
48-21	8088-8094	images	_
48-22	8095-8099	into	_
48-23	8100-8108	distinct	_
48-24	8109-8114	brain	_
48-25	8115-8122	tissues	_
48-26	8123-8124	,	_
48-27	8125-8134	smoothing	_
48-28	8135-8138	the	_
48-29	8139-8150	gray-matter	_
48-30	8151-8157	images	_
48-31	8158-8159	,	_
48-32	8160-8163	and	_
48-33	8164-8174	performing	_
48-34	8175-8176	a	_
48-35	8177-8188	statistical	_
48-36	8189-8193	test	_
48-37	8194-8196	to	_
48-38	8197-8205	localize	_
48-39	8206-8217	significant	_
48-40	8218-8230	associations	_
48-41	8231-8238	between	_
48-42	8239-8249	anatomical	_
48-43	8250-8253	and	_
48-44	8254-8264	behavioral	_
48-45	8265-8273	measures	_
48-46	8274-8275	.	_

49-1	8276-8279	VBM	_
49-2	8280-8283	was	_
49-3	8284-8293	performed	_
49-4	8294-8299	using	_
49-5	8300-8303	the	_
49-6	8304-8317	Computational	_
49-7	8318-8325	Anatomy	_
49-8	8326-8333	Toolbox	_
49-9	8334-8335	(	_
49-10	8336-8339	CAT	_
49-11	8340-8342	12	_
49-12	8343-8347	r933	_
49-13	8348-8349	,	_
49-14	8350-8354	http	_
49-15	8355-8356	:	_
49-16	8357-8385	//dbm.neuro.uni-jena.de/cat/	_
49-17	8386-8387	)	_
49-18	8388-8396	packaged	_
49-19	8397-8399	in	_
49-20	8400-8411	Statistical	_
49-21	8412-8422	Parametric	_
49-22	8423-8430	Mapping	_
49-23	8431-8433	12	_
49-24	8434-8435	(	_
49-25	8436-8444	Wellcome	_
49-26	8445-8455	Department	_
49-27	8456-8458	of	_
49-28	8459-8466	Imaging	_
49-29	8467-8479	Neuroscience	_
49-30	8480-8481	,	_
49-31	8482-8492	University	_
49-32	8493-8500	College	_
49-33	8501-8507	London	_
49-34	8508-8509	,	_
49-35	8510-8514	U.K.	_
49-36	8515-8516	)	_
49-37	8517-8518	.	_

50-1	8519-8524	CAT12	_
50-2	8525-8533	provides	_
50-3	8534-8541	several	_
50-4	8542-8552	components	_
50-5	8553-8562	optimized	_
50-6	8563-8566	for	_
50-7	8567-8578	morphometry	_
50-8	8579-8580	,	_
50-9	8581-8590	including	_
50-10	8591-8599	internal	_
50-11	8600-8613	interpolation	_
50-12	8614-8615	,	_
50-13	8616-8622	affine	_
50-14	8623-8636	preprocessing	_
50-15	8637-8638	(	_
50-16	8639-8645	affine	_
50-17	8646-8658	registration	_
50-18	8659-8661	of	_
50-19	8662-8676	bias-corrected	_
50-20	8677-8683	images	_
50-21	8684-8685	)	_
50-22	8686-8687	,	_
50-23	8688-8695	partial	_
50-24	8696-8702	volume	_
50-25	8703-8715	segmentation	_
50-26	8716-8717	,	_
50-27	8718-8727	denoising	_
50-28	8728-8729	,	_
50-29	8730-8736	DARTEL	_
50-30	8737-8750	normalization	_
50-31	8751-8752	,	_
50-32	8753-8758	local	_
50-33	8759-8767	adaptive	_
50-34	8768-8780	segmentation	_
50-35	8781-8782	,	_
50-36	8783-8798	skull-stripping	_
50-37	8799-8800	,	_
50-38	8801-8809	adaptive	_
50-39	8810-8817	maximum	_
50-40	8818-8819	a	_
50-41	8820-8830	posteriori	_
50-42	8831-8843	segmentation	_
50-43	8844-8845	,	_
50-44	8846-8849	and	_
50-45	8850-8851	a	_
50-46	8852-8857	final	_
50-47	8858-8859	“	_
50-48	8860-8868	clean-up	_
50-49	8869-8870	”	_
50-50	8871-8872	.	_

51-1	8873-8875	In	_
51-2	8876-8881	short	_
51-3	8882-8883	,	_
51-4	8884-8886	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
51-5	8887-8893	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
51-6	8894-8898	were	_
51-7	8899-8904	first	_
51-8	8905-8918	co-registered	_
51-9	8919-8921	to	_
51-10	8922-8925	the	_
51-11	8926-8934	Montreal	_
51-12	8935-8947	Neurological	_
51-13	8948-8957	Institute	_
51-14	8958-8960	or	_
51-15	8961-8964	MNI	_
51-16	8965-8973	template	_
51-17	8974-8979	space	_
51-18	8980-8981	(	_
51-19	8982-8985	1.5	_
51-20	8986-8989	mm3	_
51-21	8990-8999	isotropic	_
51-22	9000-9006	voxels	_
51-23	9007-9008	)	_
51-24	9009-9014	using	_
51-25	9015-9016	a	_
51-26	9017-9025	multiple	_
51-27	9026-9031	stage	_
51-28	9032-9038	affine	_
51-29	9039-9053	transformation	_
51-30	9054-9055	,	_
51-31	9056-9062	during	_
51-32	9063-9068	which	_
51-33	9069-9072	the	_
51-34	9073-9075	12	_
51-35	9076-9086	parameters	_
51-36	9087-9091	were	_
51-37	9092-9101	estimated	_
51-38	9102-9103	.	_

52-1	9104-9119	Co-registration	_
52-2	9120-9127	started	_
52-3	9128-9132	with	_
52-4	9133-9134	a	_
52-5	9135-9141	coarse	_
52-6	9142-9148	affine	_
52-7	9149-9161	registration	_
52-8	9162-9167	using	_
52-9	9168-9172	mean	_
52-10	9173-9179	square	_
52-11	9180-9191	differences	_
52-12	9192-9193	,	_
52-13	9194-9202	followed	_
52-14	9203-9205	by	_
52-15	9206-9212	affine	_
52-16	9213-9225	registration	_
52-17	9226-9231	using	_
52-18	9232-9238	mutual	_
52-19	9239-9250	information	_
52-20	9251-9252	.	_

53-1	9253-9255	In	_
53-2	9256-9260	this	_
53-3	9261-9265	step	_
53-4	9266-9267	,	_
53-5	9268-9280	coefficients	_
53-6	9281-9283	of	_
53-7	9284-9287	the	_
53-8	9288-9293	basis	_
53-9	9294-9303	functions	_
53-10	9304-9308	that	_
53-11	9309-9317	minimize	_
53-12	9318-9321	the	_
53-13	9322-9330	residual	_
53-14	9331-9337	square	_
53-15	9338-9348	difference	_
53-16	9349-9356	between	_
53-17	9357-9367	individual	_
53-18	9368-9373	image	_
53-19	9374-9377	and	_
53-20	9378-9381	the	_
53-21	9382-9390	template	_
53-22	9391-9395	were	_
53-23	9396-9405	estimated	_
53-24	9406-9407	.	_

54-1	9408-9414	Tissue	_
54-2	9415-9426	probability	_
54-3	9427-9431	maps	_
54-4	9432-9443	constructed	_
54-5	9444-9448	from	_
54-6	9449-9452	452	_
54-7	9453-9460	healthy	_
54-8	9461-9469	subjects	_
54-9	9470-9474	were	_
54-10	9475-9479	used	_
54-11	9480-9482	in	_
54-12	9483-9489	affine	_
54-13	9490-9504	transformation	_
54-14	9505-9506	,	_
54-15	9507-9510	and	_
54-16	9511-9517	affine	_
54-17	9518-9532	regularization	_
54-18	9533-9536	was	_
54-19	9537-9546	performed	_
54-20	9547-9551	with	_
54-21	9552-9556	ICBM	_
54-22	9557-9562	space	_
54-23	9563-9571	template	_
54-24	9572-9573	–	_
54-25	9574-9582	European	_
54-26	9583-9589	brains	_
54-27	9590-9591	.	_

55-1	9592-9598	Affine	_
55-2	9599-9612	preprocessing	_
55-3	9613-9616	was	_
55-4	9617-9626	performed	_
55-5	9627-9631	with	_
55-6	9632-9639	default	_
55-7	9640-9649	parameter	_
55-8	9650-9651	‘	_
55-9	9652-9657	light	_
55-10	9658-9659	’	_
55-11	9660-9661	.	_

56-1	9662-9667	After	_
56-2	9668-9674	affine	_
56-3	9675-9689	transformation	_
56-4	9690-9691	,	_
56-5	9692-9693	a	_
56-6	9694-9710	spatial-adaptive	_
56-7	9711-9720	non-local	_
56-8	9721-9726	means	_
56-9	9727-9736	denoising	_
56-10	9737-9743	filter	_
56-11	9744-9748	with	_
56-12	9749-9756	default	_
56-13	9757-9766	parameter	_
56-14	9767-9770	0.5	_
56-15	9771-9774	was	_
56-16	9775-9782	applied	_
56-17	9783-9784	,	_
56-18	9785-9787	to	_
56-19	9788-9795	account	_
56-20	9796-9799	for	_
56-21	9800-9809	intensity	_
56-22	9810-9820	variations	_
56-23	9821-9822	(	_
56-24	9823-9836	inhomogeneity	_
56-25	9837-9838	)	_
56-26	9839-9842	and	_
56-27	9843-9848	noise	_
56-28	9849-9855	caused	_
56-29	9856-9858	by	_
56-30	9859-9868	different	_
56-31	9869-9878	positions	_
56-32	9879-9881	of	_
56-33	9882-9889	cranial	_
56-34	9890-9900	structures	_
56-35	9901-9907	within	_
56-36	9908-9911	the	_
56-37	9912-9915	MRI	_
56-38	9916-9920	coil	_
56-39	9921-9922	;	_
56-40	9923-9926	and	_
56-41	9927-9928	,	_
56-42	9929-9936	finally	_
56-43	9937-9938	,	_
56-44	9939-9943	they	_
56-45	9944-9948	were	_
56-46	9949-9958	segmented	_
56-47	9959-9963	into	_
56-48	9964-9977	cerebrospinal	_
56-49	9978-9983	fluid	_
56-50	9984-9985	,	_
56-51	9986-9990	gray	_
56-52	9991-9997	matter	_
56-53	9998-10001	and	_
56-54	10002-10007	white	_
56-55	10008-10014	matter	_
56-56	10015-10016	,	_
56-57	10017-10022	using	_
56-58	10023-10025	an	_
56-59	10026-10034	adaptive	_
56-60	10035-10042	maximum	_
56-61	10043-10044	a	_
56-62	10045-10055	posteriori	_
56-63	10056-10062	method	_
56-64	10063-10067	with	_
56-65	10068-10075	k-means	_
56-66	10076-10091	initializations	_
56-67	10092-10093	.	_

57-1	10094-10096	In	_
57-2	10097-10109	segmentation	_
57-3	10110-10111	,	_
57-4	10112-10119	partial	_
57-5	10120-10126	volume	_
57-6	10127-10137	estimation	_
57-7	10138-10141	was	_
57-8	10142-10151	performed	_
57-9	10152-10156	with	_
57-10	10157-10158	a	_
57-11	10159-10169	simplified	_
57-12	10170-10175	mixed	_
57-13	10176-10181	model	_
57-14	10182-10184	of	_
57-15	10185-10187	at	_
57-16	10188-10192	most	_
57-17	10193-10196	two	_
57-18	10197-10203	tissue	_
57-19	10204-10209	types	_
57-20	10210-10211	,	_
57-21	10212-10215	and	_
57-22	10216-10217	a	_
57-23	10218-10223	local	_
57-24	10224-10232	adaptive	_
57-25	10233-10245	segmentation	_
57-26	10246-10249	was	_
57-27	10250-10258	executed	_
57-28	10259-10263	with	_
57-29	10264-10271	default	_
57-30	10272-10281	parameter	_
57-31	10282-10285	0.5	_
57-32	10286-10288	to	_
57-33	10289-10296	account	_
57-34	10297-10300	for	_
57-35	10301-10303	GM	_
57-36	10304-10317	inhomogeneity	_
57-37	10318-10323	prior	_
57-38	10324-10326	to	_
57-39	10327-10330	the	_
57-40	10331-10336	final	_
57-41	10337-10345	adaptive	_
57-42	10346-10353	maximum	_
57-43	10354-10355	a	_
57-44	10356-10366	posteriori	_
57-45	10367-10377	estimation	_
57-46	10378-10379	.	_

58-1	10380-10389	Segmented	_
58-2	10390-10393	and	_
58-3	10394-10397	the	_
58-4	10398-10407	initially	_
58-5	10408-10418	registered	_
58-6	10419-10425	tissue	_
58-7	10426-10431	class	_
58-8	10432-10436	maps	_
58-9	10437-10441	were	_
58-10	10442-10452	normalized	_
58-11	10453-10458	using	_
58-12	10459-10465	DARTEL	_
58-13	10466-10467	,	_
58-14	10468-10469	a	_
58-15	10470-10474	fast	_
58-16	10475-10488	diffeomorphic	_
58-17	10489-10494	image	_
58-18	10495-10507	registration	_
58-19	10508-10517	algorithm	_
58-20	10518-10520	of	_
58-21	10521-10524	SPM	_
58-22	10525-10526	.	_

59-1	10527-10529	As	_
59-2	10530-10531	a	_
59-3	10532-10548	high-dimensional	_
59-4	10549-10559	non-linear	_
59-5	10560-10567	spatial	_
59-6	10568-10581	normalization	_
59-7	10582-10588	method	_
59-8	10589-10590	,	_
59-9	10591-10597	DARTEL	_
59-10	10598-10607	generates	_
59-11	10608-10622	mathematically	_
59-12	10623-10633	consistent	_
59-13	10634-10641	inverse	_
59-14	10642-10649	spatial	_
59-15	10650-10665	transformations	_
59-16	10666-10667	.	_

60-1	10668-10670	We	_
60-2	10671-10675	used	_
60-3	10676-10679	the	_
60-4	10680-10688	standard	_
60-5	10689-10695	DARTEL	_
60-6	10696-10704	template	_
60-7	10705-10707	in	_
60-8	10708-10711	MNI	_
60-9	10712-10717	space	_
60-10	10718-10719	,	_
60-11	10720-10731	constructed	_
60-12	10732-10736	from	_
60-13	10737-10740	555	_
60-14	10741-10748	healthy	_
60-15	10749-10757	subjects	_
60-16	10758-10760	of	_
60-17	10761-10764	the	_
60-18	10765-10777	IXI-database	_
60-19	10778-10779	(	_
60-20	10780-10784	http	_
60-21	10785-10786	:	_
60-22	10787-10815	//www.brain-development.org/	_
60-23	10816-10817	)	_
60-24	10818-10819	,	_
60-25	10820-10822	to	_
60-26	10823-10828	drive	_
60-27	10829-10832	the	_
60-28	10833-10839	DARTEL	_
60-29	10840-10853	normalization	_
60-30	10854-10855	.	_

61-1	10856-10871	Skull-stripping	_
61-2	10872-10875	and	_
61-3	10876-10881	final	_
61-4	10882-10887	clean	_
61-5	10888-10890	up	_
61-6	10891-10892	(	_
61-7	10893-10895	to	_
61-8	10896-10902	remove	_
61-9	10903-10912	remaining	_
61-10	10913-10921	meninges	_
61-11	10922-10925	and	_
61-12	10926-10933	correct	_
61-13	10934-10937	for	_
61-14	10938-10944	volume	_
61-15	10945-10952	effects	_
61-16	10953-10955	in	_
61-17	10956-10960	some	_
61-18	10961-10968	regions	_
61-19	10969-10970	)	_
61-20	10971-10975	were	_
61-21	10976-10985	performed	_
61-22	10986-10990	with	_
61-23	10991-10998	default	_
61-24	10999-11009	parameters	_
61-25	11010-11012	of	_
61-26	11013-11018	0.5′s	_
61-27	11019-11020	.	_

62-1	11021-11031	Normalized	_
62-2	11032-11034	GM	_
62-3	11035-11039	maps	_
62-4	11040-11044	were	_
62-5	11045-11054	modulated	_
62-6	11055-11057	to	_
62-7	11058-11064	obtain	_
62-8	11065-11068	the	_
62-9	11069-11077	absolute	_
62-10	11078-11084	volume	_
62-11	11085-11087	of	_
62-12	11088-11090	GM	_
62-13	11091-11097	tissue	_
62-14	11098-11107	corrected	_
62-15	11108-11111	for	_
62-16	11112-11122	individual	_
62-17	11123-11128	brain	_
62-18	11129-11134	sizes	_
62-19	11135-11136	.	_

63-1	11137-11144	Finally	_
63-2	11145-11146	,	_
63-3	11147-11150	the	_
63-4	11151-11153	GM	_
63-5	11154-11158	maps	_
63-6	11159-11163	were	_
63-7	11164-11172	smoothed	_
63-8	11173-11175	by	_
63-9	11176-11186	convolving	_
63-10	11187-11191	with	_
63-11	11192-11194	an	_
63-12	11195-11204	isotropic	_
63-13	11205-11213	Gaussian	_
63-14	11214-11220	kernel	_
63-15	11221-11222	.	_

64-1	11223-11232	Smoothing	_
64-2	11233-11238	helps	_
64-3	11239-11241	in	_
64-4	11242-11254	compensating	_
64-5	11255-11258	for	_
64-6	11259-11262	the	_
64-7	11263-11270	inexact	_
64-8	11271-11277	nature	_
64-9	11278-11280	of	_
64-10	11281-11288	spatial	_
64-11	11289-11302	normalization	_
64-12	11303-11306	and	_
64-13	11307-11314	reduces	_
64-14	11315-11318	the	_
64-15	11319-11325	number	_
64-16	11326-11328	of	_
64-17	11329-11340	statistical	_
64-18	11341-11352	comparisons	_
64-19	11353-11354	;	_
64-20	11355-11362	however	_
64-21	11363-11364	,	_
64-22	11365-11367	it	_
64-23	11368-11375	reduces	_
64-24	11376-11379	the	_
64-25	11380-11388	accuracy	_
64-26	11389-11391	of	_
64-27	11392-11404	localization	_
64-28	11405-11406	.	_

65-1	11407-11411	Most	_
65-2	11412-11415	VBM	_
65-3	11416-11423	studies	_
65-4	11424-11428	used	_
65-5	11429-11430	a	_
65-6	11431-11437	kernel	_
65-7	11438-11442	size	_
65-8	11443-11445	of	_
65-9	11446-11450	FWHM	_
65-10	11451-11452	=	_
65-11	11453-11455	12	_
65-12	11456-11458	mm	_
65-13	11459-11460	.	_

66-1	11461-11463	We	_
66-2	11464-11468	used	_
66-3	11469-11470	a	_
66-4	11471-11478	smaller	_
66-5	11479-11485	kernel	_
66-6	11486-11490	size	_
66-7	11491-11493	of	_
66-8	11494-11498	FWHM	_
66-9	11499-11500	=	_
66-10	11501-11502	8	_
66-11	11503-11505	mm	_
66-12	11506-11508	to	_
66-13	11509-11516	enhance	_
66-14	11517-11529	localization	_
66-15	11530-11538	accuracy	_
66-16	11539-11540	.	_

67-1	11541-11543	In	_
67-2	11544-11549	group	_
67-3	11550-11558	analyses	_
67-4	11559-11560	,	_
67-5	11561-11563	we	_
67-6	11564-11572	employed	_
67-7	11573-11581	multiple	_
67-8	11582-11593	regressions	_
67-9	11594-11596	as	_
67-10	11597-11605	informed	_
67-11	11606-11608	by	_
67-12	11609-11612	the	_
67-13	11613-11617	best	_
67-14	11618-11622	GLMs	_
67-15	11623-11625	of	_
67-16	11626-11629	the	_
67-17	11630-11638	clinical	_
67-18	11639-11643	data	_
67-19	11644-11645	.	_

68-1	11646-11649	The	_
68-2	11650-11659	rationale	_
68-3	11660-11663	was	_
68-4	11664-11666	to	_
68-5	11667-11675	identify	_
68-6	11676-11679	the	_
68-7	11680-11686	neural	_
68-8	11687-11697	correlates	_
68-9	11698-11700	of	_
68-10	11701-11710	variables	_
68-11	11711-11715	that	_
68-12	11716-11720	best	_
68-13	11721-11730	predicted	_
68-14	11731-11736	AUDIT	_
68-15	11737-11743	within	_
68-16	11744-11748	each	_
68-17	11749-11754	group	_
68-18	11755-11756	;	_
68-19	11757-11761	that	_
68-20	11762-11764	is	_
68-21	11765-11766	,	_
68-22	11767-11769	GP	_
68-23	11770-11773	for	_
68-24	11774-11779	women	_
68-25	11780-11781	,	_
68-26	11782-11785	and	_
68-27	11786-11788	BI	_
68-28	11789-11790	×	_
68-29	11791-11793	GP	_
68-30	11794-11797	for	_
68-31	11798-11801	men	_
68-32	11802-11805	and	_
68-33	11806-11809	for	_
68-34	11810-11815	women	_
68-35	11816-11819	and	_
68-36	11820-11823	men	_
68-37	11824-11832	combined	_
68-38	11833-11834	(	_
68-39	11835-11841	please	_
68-40	11842-11845	see	_
68-41	11846-11853	Results	_
68-42	11854-11855	)	_
68-43	11856-11857	.	_

69-1	11858-11867	Therefore	_
69-2	11868-11869	,	_
69-3	11870-11872	we	_
69-4	11873-11882	regressed	_
69-5	11883-11886	the	_
69-6	11887-11889	GM	_
69-7	11890-11897	volumes	_
69-8	11898-11900	of	_
69-9	11901-11904	the	_
69-10	11905-11910	whole	_
69-11	11911-11916	brain	_
69-12	11917-11924	against	_
69-13	11925-11927	GP	_
69-14	11928-11933	score	_
69-15	11934-11937	for	_
69-16	11938-11943	women	_
69-17	11944-11945	;	_
69-18	11946-11949	and	_
69-19	11950-11952	GM	_
69-20	11953-11960	volumes	_
69-21	11961-11968	against	_
69-22	11969-11971	BI	_
69-23	11972-11973	×	_
69-24	11974-11976	GP	_
69-25	11977-11982	score	_
69-26	11983-11986	for	_
69-27	11987-11990	men	_
69-28	11991-11994	and	_
69-29	11995-11998	for	_
69-30	11999-12002	men	_
69-31	12003-12006	and	_
69-32	12007-12012	women	_
69-33	12013-12021	combined	_
69-34	12022-12023	,	_
69-35	12024-12027	all	_
69-36	12028-12032	with	_
69-37	12033-12036	age	_
69-38	12037-12039	as	_
69-39	12040-12041	a	_
69-40	12042-12051	covariate	_
69-41	12052-12053	,	_
69-42	12054-12056	as	_
69-43	12057-12061	with	_
69-44	12062-12065	GLM	_
69-45	12066-12074	analysis	_
69-46	12075-12077	of	_
69-47	12078-12081	the	_
69-48	12082-12090	clinical	_
69-49	12091-12095	data	_
69-50	12096-12097	.	_

70-1	12098-12107	Mediation	_
70-2	12108-12116	analysis	_
70-3	12117-12119	We	_
70-4	12120-12128	examined	_
70-5	12129-12136	whether	_
70-6	12137-12140	GMV	_
70-7	12141-12150	variation	_
70-8	12151-12153	of	_
70-9	12154-12157	the	_
70-10	12158-12165	regions	_
70-11	12166-12168	of	_
70-12	12169-12177	interest	_
70-13	12178-12186	mediates	_
70-14	12187-12190	the	_
70-15	12191-12202	correlation	_
70-16	12203-12210	between	_
70-17	12211-12218	alcohol	_
70-18	12219-12229	expectancy	_
70-19	12230-12231	(	_
70-20	12232-12234	GP	_
70-21	12235-12236	)	_
70-22	12237-12239	or	_
70-23	12240-12243	the	_
70-24	12244-12255	interaction	_
70-25	12256-12263	between	_
70-26	12264-12275	impulsivity	_
70-27	12276-12279	and	_
70-28	12280-12287	alcohol	_
70-29	12288-12298	expectancy	_
70-30	12299-12300	(	_
70-31	12301-12303	BI	_
70-32	12304-12305	×	_
70-33	12306-12308	GP	_
70-34	12309-12310	)	_
70-35	12311-12314	and	_
70-36	12315-12322	problem	_
70-37	12323-12331	drinking	_
70-38	12332-12333	(	_
70-39	12334-12336	as	_
70-40	12337-12344	indexed	_
70-41	12345-12347	by	_
70-42	12348-12353	AUDIT	_
70-43	12354-12359	score	_
70-44	12360-12361	)	_
70-45	12362-12363	,	_
70-46	12364-12368	with	_
70-47	12369-12372	age	_
70-48	12373-12375	as	_
70-49	12376-12385	covariate	_
70-50	12386-12387	.	_

71-1	12388-12390	We	_
71-2	12391-12400	performed	_
71-3	12401-12410	mediation	_
71-4	12411-12419	analyses	_
71-5	12420-12421	,	_
71-6	12422-12427	using	_
71-7	12428-12431	the	_
71-8	12432-12439	toolbox	_
71-9	12440-12442	M3	_
71-10	12443-12444	,	_
71-11	12445-12454	developed	_
71-12	12455-12457	by	_
71-13	12458-12461	Tor	_
71-14	12462-12467	Wager	_
71-15	12468-12471	and	_
71-16	12472-12478	Martin	_
71-17	12479-12481	A.	_
71-18	12482-12491	Lindquist	_
71-19	12492-12493	(	_
71-20	12494-12498	http	_
71-21	12499-12500	:	_
71-22	12501-12530	//wagerlab.colorado.edu/tools	_
71-23	12531-12532	)	_
71-24	12533-12534	.	_

72-1	12535-12542	Regions	_
72-2	12543-12545	of	_
72-3	12546-12554	interest	_
72-4	12555-12556	(	_
72-5	12557-12560	ROI	_
72-6	12561-12562	)	_
72-7	12563-12567	were	_
72-8	12568-12575	derived	_
72-9	12576-12580	from	_
72-10	12581-12586	group	_
72-11	12587-12594	results	_
72-12	12595-12598	and	_
72-13	12599-12602	the	_
72-14	12603-12606	GMV	_
72-15	12607-12609	of	_
72-16	12610-12615	these	_
72-17	12616-12620	ROIs	_
72-18	12621-12623	of	_
72-19	12624-12634	individual	_
72-20	12635-12647	participants	_
72-21	12648-12652	were	_
72-22	12653-12661	obtained	_
72-23	12662-12664	by	_
72-24	12665-12674	averaging	_
72-25	12675-12678	the	_
72-26	12679-12684	voxel	_
72-27	12685-12687	GM	_
72-28	12688-12694	volume	_
72-29	12695-12704	densities	_
72-30	12705-12711	within	_
72-31	12712-12716	each	_
72-32	12717-12727	individual	_
72-33	12728-12734	region	_
72-34	12735-12736	.	_

73-1	12737-12739	In	_
73-2	12740-12741	a	_
73-3	12742-12751	mediation	_
73-4	12752-12760	analysis	_
73-5	12761-12762	,	_
73-6	12763-12766	the	_
73-7	12767-12775	relation	_
73-8	12776-12783	between	_
73-9	12784-12787	the	_
73-10	12788-12799	independent	_
73-11	12800-12808	variable	_
73-12	12809-12810	X	_
73-13	12811-12814	and	_
73-14	12815-12824	dependent	_
73-15	12825-12833	variable	_
73-16	12834-12835	Y	_
73-17	12836-12837	,	_
73-18	12838-12841	i.e	_
73-19	12842-12843	.	_

74-1	12844-12847	X➔Y	_
74-2	12848-12849	,	_
74-3	12850-12852	is	_
74-4	12853-12859	tested	_
74-5	12860-12862	to	_
74-6	12863-12866	see	_
74-7	12867-12869	if	_
74-8	12870-12872	it	_
74-9	12873-12875	is	_
74-10	12876-12889	significantly	_
74-11	12890-12898	mediated	_
74-12	12899-12901	by	_
74-13	12902-12903	a	_
74-14	12904-12912	variable	_
74-15	12913-12915	M.	_
74-16	12916-12919	The	_
74-17	12920-12929	mediation	_
74-18	12930-12934	test	_
74-19	12935-12937	is	_
74-20	12938-12947	performed	_
74-21	12948-12950	by	_
74-22	12951-12960	employing	_
74-23	12961-12966	three	_
74-24	12967-12977	regression	_
74-25	12978-12987	equations	_
74-26	12988-12989	:	_
74-27	12990-12991	Y	_
74-28	12992-12993	=	_
74-29	12994-12996	i1	_
74-30	12997-12998	+	_
74-31	12999-13001	cX	_
74-32	13002-13003	+	_
74-33	13004-13006	e1	_
74-34	13007-13008	Y	_
74-35	13009-13010	=	_
74-36	13011-13013	i2	_
74-37	13014-13015	+	_
74-38	13016-13019	c′X	_
74-39	13020-13021	+	_
74-40	13022-13024	bM	_
74-41	13025-13026	+	_
74-42	13027-13029	e2	_
74-43	13030-13031	M	_
74-44	13032-13033	=	_
74-45	13034-13036	i3	_
74-46	13037-13038	+	_
74-47	13039-13041	aX	_
74-48	13042-13043	+	_
74-49	13044-13046	e3	_
74-50	13047-13052	where	_
74-51	13053-13054	a	_
74-52	13055-13065	represents	_
74-53	13066-13069	X➔M	_
74-54	13070-13071	,	_
74-55	13072-13073	b	_
74-56	13074-13084	represents	_
74-57	13085-13088	M➔Y	_
74-58	13089-13090	(	_
74-59	13091-13102	controlling	_
74-60	13103-13106	for	_
74-61	13107-13108	X	_
74-62	13109-13110	)	_
74-63	13111-13112	,	_
74-64	13113-13115	c′	_
74-65	13116-13126	represents	_
74-66	13127-13130	X➔Y	_
74-67	13131-13132	(	_
74-68	13133-13144	controlling	_
74-69	13145-13148	for	_
74-70	13149-13150	M	_
74-71	13151-13152	)	_
74-72	13153-13154	,	_
74-73	13155-13158	and	_
74-74	13159-13160	c	_
74-75	13161-13171	represents	_
74-76	13172-13175	X➔Y	_
74-77	13176-13177	.	_

75-1	13178-13181	The	_
75-2	13182-13191	constants	_
75-3	13192-13194	i1	_
75-4	13195-13196	,	_
75-5	13197-13199	i2	_
75-6	13200-13201	,	_
75-7	13202-13204	i3	_
75-8	13205-13208	are	_
75-9	13209-13212	the	_
75-10	13213-13223	intercepts	_
75-11	13224-13225	,	_
75-12	13226-13229	and	_
75-13	13230-13232	e1	_
75-14	13233-13234	,	_
75-15	13235-13237	e2	_
75-16	13238-13239	,	_
75-17	13240-13242	e3	_
75-18	13243-13246	are	_
75-19	13247-13250	the	_
75-20	13251-13259	residual	_
75-21	13260-13266	errors	_
75-22	13267-13268	.	_

76-1	13269-13271	In	_
76-2	13272-13275	the	_
76-3	13276-13286	literature	_
76-4	13287-13288	,	_
76-5	13289-13290	a	_
76-6	13291-13292	,	_
76-7	13293-13294	b	_
76-8	13295-13296	,	_
76-9	13297-13298	c	_
76-10	13299-13302	and	_
76-11	13303-13305	c′	_
76-12	13306-13310	were	_
76-13	13311-13319	referred	_
76-14	13320-13322	as	_
76-15	13323-13327	path	_
76-16	13328-13340	coefficients	_
76-17	13341-13343	or	_
76-18	13344-13350	simply	_
76-19	13351-13356	paths	_
76-20	13357-13358	,	_
76-21	13359-13362	and	_
76-22	13363-13365	we	_
76-23	13366-13374	followed	_
76-24	13375-13379	this	_
76-25	13380-13388	notation	_
76-26	13389-13390	.	_

77-1	13391-13399	Variable	_
77-2	13400-13401	M	_
77-3	13402-13404	is	_
77-4	13405-13409	said	_
77-5	13410-13412	to	_
77-6	13413-13415	be	_
77-7	13416-13417	a	_
77-8	13418-13426	mediator	_
77-9	13427-13429	of	_
77-10	13430-13433	the	_
77-11	13434-13445	correlation	_
77-12	13446-13449	X➔Y	_
77-13	13450-13452	if	_
77-14	13453-13454	(	_
77-15	13455-13456	c	_
77-16	13457-13458	−	_
77-17	13459-13460	c	_
77-18	13461-13462	’	_
77-19	13463-13464	)	_
77-20	13465-13466	,	_
77-21	13467-13472	which	_
77-22	13473-13475	is	_
77-23	13476-13490	mathematically	_
77-24	13491-13501	equivalent	_
77-25	13502-13504	to	_
77-26	13505-13508	the	_
77-27	13509-13516	product	_
77-28	13517-13519	of	_
77-29	13520-13523	the	_
77-30	13524-13529	paths	_
77-31	13530-13531	a	_
77-32	13532-13533	×	_
77-33	13534-13535	b	_
77-34	13536-13537	,	_
77-35	13538-13540	is	_
77-36	13541-13554	significantly	_
77-37	13555-13564	different	_
77-38	13565-13569	from	_
77-39	13570-13574	zero	_
77-40	13575-13576	.	_

78-1	13577-13579	If	_
78-2	13580-13583	the	_
78-3	13584-13591	product	_
78-4	13592-13593	a	_
78-5	13594-13595	×	_
78-6	13596-13597	b	_
78-7	13598-13601	and	_
78-8	13602-13605	the	_
78-9	13606-13611	paths	_
78-10	13612-13613	a	_
78-11	13614-13617	and	_
78-12	13618-13619	b	_
78-13	13620-13623	are	_
78-14	13624-13635	significant	_
78-15	13636-13637	,	_
78-16	13638-13641	one	_
78-17	13642-13651	concludes	_
78-18	13652-13656	that	_
78-19	13657-13660	X➔Y	_
78-20	13661-13663	is	_
78-21	13664-13672	mediated	_
78-22	13673-13675	by	_
78-23	13676-13678	M.	_
78-24	13679-13681	In	_
78-25	13682-13690	addition	_
78-26	13691-13692	,	_
78-27	13693-13695	if	_
78-28	13696-13700	path	_
78-29	13701-13703	c′	_
78-30	13704-13706	is	_
78-31	13707-13710	not	_
78-32	13711-13722	significant	_
78-33	13723-13724	,	_
78-34	13725-13730	there	_
78-35	13731-13733	is	_
78-36	13734-13736	no	_
78-37	13737-13743	direct	_
78-38	13744-13754	connection	_
78-39	13755-13759	from	_
78-40	13760-13761	X	_
78-41	13762-13764	to	_
78-42	13765-13766	Y	_
78-43	13767-13770	and	_
78-44	13771-13775	that	_
78-45	13776-13779	X➔Y	_
78-46	13780-13782	is	_
78-47	13783-13793	completely	_
78-48	13794-13802	mediated	_
78-49	13803-13805	by	_
78-50	13806-13808	M.	_
78-51	13809-13813	Note	_
78-52	13814-13818	that	_
78-53	13819-13823	path	_
78-54	13824-13825	b	_
78-55	13826-13828	is	_
78-56	13829-13832	the	_
78-57	13833-13841	relation	_
78-58	13842-13849	between	_
78-59	13850-13851	Y	_
78-60	13852-13855	and	_
78-61	13856-13857	M	_
78-62	13858-13859	,	_
78-63	13860-13871	controlling	_
78-64	13872-13875	for	_
78-65	13876-13877	X	_
78-66	13878-13879	,	_
78-67	13880-13883	and	_
78-68	13884-13890	should	_
78-69	13891-13894	not	_
78-70	13895-13897	be	_
78-71	13898-13906	confused	_
78-72	13907-13911	with	_
78-73	13912-13915	the	_
78-74	13916-13927	correlation	_
78-75	13928-13939	coefficient	_
78-76	13940-13947	between	_
78-77	13948-13949	Y	_
78-78	13950-13953	and	_
78-79	13954-13955	M	_
78-80	13956-13957	.	_

